BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 20857885)

  • 1. Psychotropic medication management in a residential group care program.
    Spellman DF; Griffith AK; Huefner JC; Wise N; McElderry E; Leslie LK
    Child Welfare; 2010; 89(2):151-67. PubMed ID: 20857885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of psychotropic medications by youths in therapeutic foster care and group homes.
    Breland-Noble AM; Elbogen EB; Farmer EM; Dubs MS; Wagner HR; Burns BJ
    Psychiatr Serv; 2004 Jun; 55(6):706-8. PubMed ID: 15175471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polypharmacy reduction in youth in a residential treatment center leads to positive treatment outcomes and significant cost savings.
    van Wattum PJ; Fabius C; Roos C; Smith C; Johnson T
    J Child Adolesc Psychopharmacol; 2013 Nov; 23(9):620-7. PubMed ID: 24251644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of abuse and gender on psychopathology, behavioral disturbance, and psychotropic medication count for youth in residential treatment.
    Badura Brack A; Huefner JC; Handwerk ML
    Am J Orthopsychiatry; 2012 Oct; 82(4):562-72. PubMed ID: 23039354
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication utilization at a group-home residential facility for children and adolescents.
    Handwerk ML; Smith GL; Thompson RW; Spellman DF; Daly DL
    J Child Adolesc Psychopharmacol; 2008 Oct; 18(5):517-25. PubMed ID: 18928416
    [TBL] [Abstract][Full Text] [Related]  

  • 6. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Psychotropic medication changes, polypharmacy, and the risk of early readmission in suicidal adolescent inpatients.
    Fontanella CA; Bridge JA; Campo JV
    Ann Pharmacother; 2009 Dec; 43(12):1939-47. PubMed ID: 19934394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic medication patterns among youth in foster care.
    Zito JM; Safer DJ; Sai D; Gardner JF; Thomas D; Coombes P; Dubowski M; Mendez-Lewis M
    Pediatrics; 2008 Jan; 121(1):e157-63. PubMed ID: 18166534
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical decision-making for 'as needed' medications in mental health care.
    Usher K; Baker JA; Holmes C; Stocks B
    J Adv Nurs; 2009 May; 65(5):981-91. PubMed ID: 19291187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can psychotropic medications change ethnoculturally determined behavior?
    Jacobsen FM
    Cult Divers Ment Health; 1995; 1(1):67-72. PubMed ID: 9225549
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Innovations in implementation of trauma-informed care practices in youth residential treatment: a curriculum for organizational change.
    Hummer VL; Dollard N; Robst J; Armstrong MI
    Child Welfare; 2010; 89(2):79-95. PubMed ID: 20857881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychotropic medication in the elderly. A survey of prescribing and clinical outcome.
    Olsen RB; Gydesen SU; Kristensen M; Eschen FT; Sørensen C; Hasle H; Lund S; Baastrup PC; Gylding-Sabroe J
    Dan Med Bull; 1990 Oct; 37(5):455-9. PubMed ID: 1980241
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Commentary on residential group care.
    Mabry RN
    Child Welfare; 2010; 89(2):15-20. PubMed ID: 20857877
    [No Abstract]   [Full Text] [Related]  

  • 14. Prescribing practices of psychiatrists and primary care physicians caring for children with mental illness.
    Harpaz-Rotem I; Rosenheck RA
    Child Care Health Dev; 2006 Mar; 32(2):225-37. PubMed ID: 16441857
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined pharmacotherapy in children and adolescents in a residential treatment center.
    Connor DF; Ozbayrak KR; Kusiak KA; Caponi AB; Melloni RH
    J Am Acad Child Adolesc Psychiatry; 1997 Feb; 36(2):248-54. PubMed ID: 9031578
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Psychiatric Practice Guidelines on Medication Costs and Youth Aggression in a Juvenile Justice Residential Treatment Program.
    Lee TG; Walker SC; Bishop AS
    Psychiatr Serv; 2016 Feb; 67(2):214-20. PubMed ID: 26423102
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric psychopharmacology for the major psychiatric disorders found in the residential treatment setting.
    Shoaf TL
    Child Adolesc Psychiatr Clin N Am; 2004 Apr; 13(2):327-45. PubMed ID: 15062349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychotropic use in community residential care facilities: A prospective cohort study.
    Lakey SL; Gray SL; Sales AE; Sullivan J; Hedrick SC
    Am J Geriatr Pharmacother; 2006 Sep; 4(3):227-35. PubMed ID: 17062323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with psychotropic drugs in various facilities for mentally handicapped patients].
    Meins W; Auwetter J; Krausz M; Turnier Y
    Nervenarzt; 1993 Jul; 64(7):451-5. PubMed ID: 8103571
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modernizing residential treatment centers for children and youth--an informed approach to improve long-term outcomes: the Damar pilot.
    Holstead J; Dalton J; Horne A; Lamond D
    Child Welfare; 2010; 89(2):115-30. PubMed ID: 20857883
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.